AC Immune SA - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACIU Nasdaq 2836 www.acimmune.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AC Immune SA

BNTX Ends Colorectal Cancer Immunotherapy Study, Stock Down - Aug 31st, 2026 10:32 am
LLY's Mounjaro Gets FDA Nod to Cut Cardiovascular Risk in Diabetes - Aug 31st, 2026 8:03 am
Here's Why You Should Add ARQT Stock to Your Portfolio Now - Aug 28th, 2026 8:58 am
Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection - Aug 28th, 2026 8:41 am
FDA Accepts United Therapeutics' NDA Filing for Ralinepag in PAH - Aug 28th, 2026 7:22 am
AZN/AMGN's Tezspire Hits Primary Goal in Eosinophilic Esophagitis Study - Aug 27th, 2026 8:57 am
BHVN Stock Soars 18% on $795M Out-Licensing Deal for Epilepsy Program - Aug 27th, 2026 7:42 am
JAZZ Secures FDA Nod for Expanded Use of Ziihera in Gastric Cancer - Aug 26th, 2026 10:29 am
SYRE Stock Sinks After Mixed SKYWAY Study Data in Rheumatoid Arthritis - Aug 26th, 2026 10:10 am
RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy - Aug 25th, 2026 9:07 am
Here's Why You Should Add ACET Stock to Your Portfolio Now - Aug 24th, 2026 8:09 am
Acadia Gets European Commission Nod for Daybu in Rett Syndrome - Aug 24th, 2026 8:04 am
Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why? - Aug 21st, 2026 9:39 am
RARE Stock Gains on FDA Nod for Rare Disease Gene Therapy Genglycos - Aug 20th, 2026 8:16 am
AC Immune shares rise after encouraging early Phase 1 data for ACI-19764 - Aug 20th, 2026 7:35 am
AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764 - Aug 20th, 2026 5:00 am
Kodiak's Q2 Loss Wider Than Expected, Pipeline Development in Focus - Aug 14th, 2026 8:14 am
CRMD Stock Up as Q2 Earnings & Sales Beat on DefenCath, Melinta Gains - Aug 14th, 2026 7:43 am
ACIU Stock Heads For Best Day In Over 10 Months On FDA Fast Track Nod For Parkinson’s Disease Therapy – Retail Sees ‘Breakout Soon’ - Aug 11th, 2026 10:18 am
AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD) - Aug 11th, 2026 5:00 am